Because VEGF is produced from normal vascular or interstitial cells, and its receptors are widely expressed in endothelial cells, enhanced CTL-mediating cellular toxicity for long term may induce the side effect in terms of safety issue such as hypertension, myocardial and cerebrovascular infarction. The gene discussed is VEGFA; the disease is hypertensive disorder.